According to SPER Market Research, the peptide synthesis market estimated to reach USD 908 million by 2030 with a CAGR of 6.5%.
Rising prevalence of chronic diseases worldwide and increasing applications of peptides in various therapeutic areas are growth drivers for the peptide synthesis market.
Peptides are small chain of amino acids. Some of the peptides have therapeutic benefits in renal, cardiovascular and neurological diseases. In COVID-19 pandemic, research and development has been emphasised for the immunization against the coronavirus utilizing peptide-based vaccines.
According to the WHO, diabetes caused over 1.5 million deaths and cardiovascular disease caused about 17.9 million deaths in 2019. The prevalence of chronic diseases is increasing due to unhealthy diet, sedentary lifestyle, alcohol abuse to name a few. Peptides have wide range of therapeutic applications for the management of many diseases.
Peptides are used in various industries such as cosmetics, pharmaceuticals and biotechnology. In the forecast period, factors such as increase in investment for research and development, rising demand for personalized treatment and health benefits of peptides are contributing to the growth of this market.
The reagents market is the largest product & service segment by share in this market. The large share of this segment is mainly ascribed by various therapeutic applications of peptides, frequent purchase required for reagents as compared to equipment and increasing R&D activities for therapeutic peptides. North America conquered the market by regional segmentation owing to rising global burden of chronic diseases, increasing interest in genomics and proteomics, increasing funding for development of structure-based drug design and rising appeal for personalized medicines.
The global peptide synthesis market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as AAPPTec, Advanced Chemtech, AmbioPharm Inc., AnyGen Co., Ltd., Aurigene Pharmaceutical Services Ltd., Bachem Holding AG, Bio-Synthesis Inc., Biotage AB, CEM Corporation, ChemPep Inc., Corden Pharma International, CPC Scientific Inc., CSBio, Dalton Pharma Services, GenScript Biotech Corporation, JPT Peptide Technologies GmbH, Kaneka Corporation, Luxembourg Bio Technologies Ltd., Merck KGaA, Mesa Laboratories inc., ProteoGenix, Purolite Pvt Ltd., Syngene International Ltd., Thermo Fisher Scientific, Vivitide.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides statistics for growth estimates and forecasts for product & service segment- Reagents, Equipment, Services; for reagents segment- Resins, Amino acids, Coupling Reagents, Dyes and Fluorescent labeling reagents, Other Reagents; for equipment segment- Peptide Synthesizers, Chromatography Equipment, Lyophiizers; for technology segment- Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid & Recombinant Technology; for end user segment- Pharmaceutical & Biotechnology companies, CDMOs & CROs, Academic & Research Institutes. This forecast report also provides the details for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining circumstances for this market for the forecast period. Various growth opportunities are also discussed in the report.